University of Cambridge Spin-out Wins Start-Up of the Year at Independent Awards

Pharmaceutical Technology Editors

Elis Biomed has been announced as the winner of the Start-Up of the Year Category for the 2018 Cambridge Independent Science and Technology Awards.

Elpis Biomed, a spin-out company from the University of Cambridge that is focused on synthetic biology, has been announced as the winner of the Start-Up of the Year category at the 2018 Cambridge Independent Science and Technology Awards.

“Elpis is set to have a transformative impact in the fields of biomedical research, drug discovery, and cell therapy,” stated the company’s scientific founder, Dr. Mark Kotter in a Nov. 16, 2018, press release. “We have assembled a world-class team to fulfill our mission to ‘make cells easy’. I am honored that our efforts have been recognized by such an outstanding panel of technology experts and that Elpis has been chosen as Start-Up of the Year from a field of truly excellent start-up companies.”

The company was selected by a panel of industry experts from a short list of start-ups, including Fluidic Analytics, Evonetix, PredictImmune, and Kalium Diagnostics. One of the judging panel, Paul Brackley (editor of the Cambridge Independent) commented, “It was an extremely high-quality field-a real showcase of the tremendous talent in this region.”

Kotter and Elpis Biomed’s commercial director, Dr Gordana Apic, were presented with the award at a ceremony held at the Hilton Cambridge City Center Hotel early in November.

Source: Elpis Biomed